RxDoctor Payments Data

Palak Parekh

Acute Care · Pennington, NJNPI 1407512247

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,724 of the $2,074 with a category attached, or 83.1%. 29 manufacturers reported payments, led by Gilead at 39.7% of the total. 2025 is the largest year on record at $1,754, more than ten times the $88 reported in 2022.

$2,074in general payments, 2019–2025

Across 54 payments — averaging $38.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$824
  • Novo Nordisk$140
  • Insmed, Inc.$101
  • Sobi, Inc$96
  • Incyte Corporation$91
  • Seagen Inc.$80
  • plus $742 from 23 others

What the payments were for

  • Food & beverage$1,72483%
  • Education$35017%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,074 in reported general payments places this provider in the 85th percentile of 656 acute care providers in New Jersey.

See all acute care providers in New Jersey →

Other acute care in Pennington

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →